| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |